SCHEMBL8478663

SCHEMBL8478663

O=C(O)CN1CCNCCN(CC(=O)O)C(CC(O)CCCCCCCCCOc2ccc(OCc3ccccc3)cc2)CN(CC(=O)O)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.49
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
HTT P42858 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPY1R P25929 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.40
POLB P06746 1/20 0.39
LTA4H P09960 1/20 0.38
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479012 0.91 ESRRG (0.39) EGFRITGB3ITGA2BALDH1A1KDM4E
SCHEMBL8537606 0.80 L3MBTL1 (0.56) ALDH1A1KDM4ERAB9ANPC1HTT
SCHEMBL8478346 0.79 KDM1A (0.41) EGFRALDH1A1L3MBTL1SMN1; SMN2POLB
SCHEMBL8477764 0.79 MAPT (0.41) EGFRALDH1A1SMN1; SMN2MAPT
SCHEMBL8478646 0.79 MAPT (0.39) EGFRALDH1A1L3MBTL1SMN1; SMN2MAPT
SCHEMBL8478625 0.79 EGFR (0.45) EGFRITGB3ITGA2BALDH1A1KDM4E
SCHEMBL8482595 0.78 S1PR1 (0.37) EGFRITGB3ITGA2BALDH1A1SMN1; SMN2
SCHEMBL8482399 0.78 KDM4E (0.41) ALDH1A1KDM4EL3MBTL1POLBMAPT
SCHEMBL8478317 0.78 ITGB3 (0.41) EGFRITGB3ITGA2BALDH1A1L3MBTL1
SCHEMBL7265773 0.76 EGFR (0.45) EGFRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5871709-A TETRAAZACYCLODODECANE COMPOUNDS SUBSTITUTED WITH ALKYL CARBOXY COMPOUNDS FOR CARDIOVASCULAR DISORDERS AND BRAIN TUMORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-02-16 US disclosed